Research analysts at StockNews.com initiated coverage on shares of Riverview Bancorp (NASDAQ:RVSB – Get Free Report) in a report released on Wednesday. The firm set a “hold” rating on the savings and loans company’s stock.
Riverview Bancorp Price Performance
Shares of NASDAQ:RVSB opened at $4.71 on Wednesday. The business has a 50 day moving average price of $4.56 and a 200 day moving average price of $4.31. Riverview Bancorp has a twelve month low of $3.30 and a twelve month high of $6.57. The company has a market cap of $99.38 million, a price-to-earnings ratio of 26.17 and a beta of 0.77. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.92.
Riverview Bancorp (NASDAQ:RVSB – Get Free Report) last announced its earnings results on Thursday, July 25th. The savings and loans company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.01). Riverview Bancorp had a net margin of 2.86% and a return on equity of 3.69%. The business had revenue of $17.77 million for the quarter, compared to the consensus estimate of $12.20 million. Research analysts predict that Riverview Bancorp will post 0.16 earnings per share for the current year.
Institutional Inflows and Outflows
Riverview Bancorp Company Profile
Riverview Bancorp, Inc operates as a bank holding company for Riverview Bank that provides commercial banking services to small and medium size businesses, professionals, and wealth building individuals. It offers a range of deposit products, including demand deposits, negotiable order of withdrawal accounts, money market accounts, savings accounts, certificates of deposit, and retirement savings plans.
Featured Stories
- Five stocks we like better than Riverview Bancorp
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Options Trading – Understanding Strike Price
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Plot Fibonacci Price Inflection Levels
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Riverview Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Riverview Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.